Lung cancer.
作者信息
Fong Kwun M
机构信息
Department of Thoracic Medicine, The Prince Charles Hospital; Professor, School of Medicine, The University of Queensland; Director UQ Thoracic Research Ctr at TPCH; Rode Road, Chermside, Brisbane 4032, Australia.
出版信息
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S452-3. doi: 10.3978/j.issn.2072-1439.2013.10.04.
Abstract
摘要
相似文献
1
Lung cancer.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S452-3. doi: 10.3978/j.issn.2072-1439.2013.10.04.
2
Metachronous lung cancer that presented as bilateral synchronous lung cancer.
J Thorac Dis. 2013 Jun;5(3):E87-9. doi: 10.3978/j.issn.2072-1439.2013.04.16.
3
Diagnostic workup of lung cancer.
Surg Oncol Clin N Am. 2011 Oct;20(4):667-79. doi: 10.1016/j.soc.2011.08.003.
4
[The general measurement of genetic factors on lung cancer in Xuanwei, China].
Zhongguo Fei Ai Za Zhi. 2001 Oct 20;4(5):354-6. doi: 10.3779/j.issn.1009-3419.2001.05.11.
5
Possible Oncogenic Viruses Associated with Lung Cancer.
Onco Targets Ther. 2020 Oct 20;13:10651-10666. doi: 10.2147/OTT.S263976. eCollection 2020.
6
Economic issues in lung cancer.
Semin Respir Crit Care Med. 2000;21(5):375-84. doi: 10.1055/s-2000-9400.
7
Advances in clinical trials of targeted therapy and immunotherapy of lung cancer in 2018.
Transl Lung Cancer Res. 2019 Dec;8(6):1091-1106. doi: 10.21037/tlcr.2019.10.17.
8
Epidemiology of Lung Cancer.
Surg Oncol Clin N Am. 2016 Jul;25(3):439-45. doi: 10.1016/j.soc.2016.02.001.
9
Lung cancer screening update.
J Carcinog. 2013 Jan 31;12:2. doi: 10.4103/1477-3163.106681. Print 2013.
10
Epidemiology of lung cancer in China.
Thorac Cancer. 2015 Mar;6(2):209-15. doi: 10.1111/1759-7714.12169. Epub 2015 Mar 2.
本文引用的文献
1
Supportive and palliative care for lung cancer patients.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S623-8. doi: 10.3978/j.issn.2072-1439.2013.10.05.
2
A review of clinical practice guidelines for lung cancer.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S607-22. doi: 10.3978/j.issn.2072-1439.2013.07.37.
3
Surgery in 2013 and beyond.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S593-606. doi: 10.3978/j.issn.2072-1439.2013.07.39.
4
Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S579-92. doi: 10.3978/j.issn.2072-1439.2013.08.52.
5
Chemotherapy advances in small-cell lung cancer.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S565-78. doi: 10.3978/j.issn.2072-1439.2013.07.43.
6
The continuing role of chemotherapy for advanced non-small cell lung cancer in the targeted therapy era.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S556-64. doi: 10.3978/j.issn.2072-1439.2013.08.47.
7
Recent advances in radiotherapy for thoracic tumours.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S551-5. doi: 10.3978/j.issn.2072-1439.2013.08.46.
8
Exhaled breath analysis for lung cancer.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S540-50. doi: 10.3978/j.issn.2072-1439.2013.08.44.
9
Screening for lung cancer with low-dose computed tomography: a review of current status.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S524-39. doi: 10.3978/j.issn.2072-1439.2013.09.06.
10
Modern diagnostic and therapeutic interventional radiology in lung cancer.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S511-23. doi: 10.3978/j.issn.2072-1439.2013.07.27.
Zotero 插件